8-KAccepted Oct 19, 4:51 PM ET
Supernus Pharmaceuticals: will report Q3 2026 results Oct 29
Accepted (ET)
4:51 PM
Oct 19, 2026
Filed
Oct 19, 2026
Documents
13
Size
165.0 KB
Summary
Supernus Pharmaceuticals: will report Q3 2026 results Oct 29
What happened On Oct 19, 2026, Supernus Pharmaceuticals, Inc. issued a press release announcing that it will report its business results for the 3rd quarter of 2026 after the market closes on Thursday, Oct 29, 2026. The company will host a conference call and webcast on Thursday, Oct 29, 2026 at 4:30 p.m. E.T. to discuss its 3rd quarter 2026 financial and business results.
Key details
- Press release issued on Oct 19, 2026.
- Company will report 3rd-quarter 2026 business results after the market closes on Thursday, Oct 29, 2026.
- Conference call and webcast scheduled for Thursday, Oct 29, 2026 at 4:30 p.m. E.T.
Why it may matter This filing reports Item 2.02: results of operations and financial condition, which covers the timing and format for the company’s release of 3rd-quarter 2026 results and the accompanying call to discuss financial and business results. The filing does not show why the insider traded or why the company acted.